Literature DB >> 16605049

Postmastectomy radiotherapy.

J A Dewar1.   

Abstract

Radiotherapy given after mastectomy (PMRT) will reduce the risk of local recurrence by about two-thirds. The absolute benefit will depend on the risk of local recurrence, which will depend on pathological characteristics (tumour size, nodal status, etc.) but also the type and extent of the surgery. The overall effect of radiotherapy on survival has changed with time. Improved local control reduces the risk of dying from breast caner, presumably by preventing secondary dissemination from recurrent disease. Older radiotherapy techniques were associated with an excess risk of cardiovascular death, which counterbalanced the improvement in survival seen with better local control. More recent studies show that modern radiotherapy techniques can improve local control and avoid cardiac morbidity. PMRT remains an important component of the management of patients with breast cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16605049     DOI: 10.1016/j.clon.2005.11.006

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  4 in total

Review 1.  Achieving autologous breast reconstruction for breast cancer patients in the setting of post-mastectomy radiotherapy.

Authors:  Namrata S Anavekar; Warren M Rozen; Cara M Le Roux; Mark W Ashton
Journal:  J Cancer Surviv       Date:  2010-11-26       Impact factor: 4.442

Review 2.  Long term physical sequelae after adult-onset cancer.

Authors:  Sophie D Fosså; Rena Vassilopoulou-Sellin; Alv A Dahl
Journal:  J Cancer Surviv       Date:  2007-12-04       Impact factor: 4.442

3.  Non-compliance with a postmastectomy radiotherapy guideline: decision tree and cause analysis.

Authors:  Amir R Razavi; Hans Gill; Hans Ahlfeldt; Nosrat Shahsavar
Journal:  BMC Med Inform Decis Mak       Date:  2008-09-21       Impact factor: 2.796

4.  The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women.

Authors:  Jingxian Ding; Yonghong Guo; Qingge Li; Jun Chen; Pinghua Hu; Qiuming Liu; Yali Cao; Jiong Wu
Journal:  Onco Targets Ther       Date:  2018-03-23       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.